Alkeon Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.7M | Buy |
4,504,096
+500,000
| +12% | +$5.08M | 0.08% | 61 |
|
|
2025
Q1 | $22.3M | Buy |
4,004,096
+100,000
| +3% | +$558K | 0.05% | 68 |
|
|
2024
Q4 | $31.5M | Hold |
3,904,096
| – | – | 0.06% | 59 |
|
|
2024
Q3 | $40M | Buy |
3,904,096
+100,000
| +3% | +$1.03M | 0.07% | 59 |
|
|
2024
Q2 | $26.9M | Buy |
3,804,096
+100,000
| +3% | +$707K | 0.04% | 67 |
|
|
2024
Q1 | $50.9M | Buy |
3,704,096
+100,000
| +3% | +$1.38M | 0.09% | 56 |
|
|
2023
Q4 | $33.2M | Buy |
3,604,096
+124,807
| +4% | +$1.15M | 0.07% | 62 |
|
|
2023
Q3 | $21M | Buy |
3,479,289
+500,000
| +17% | +$3.03M | 0.04% | 67 |
|
|
2023
Q2 | $23.1M | Buy |
2,979,289
+580,037
| +24% | +$4.5M | 0.04% | 71 |
|
|
2023
Q1 | $13.7M | Hold |
2,399,252
| – | – | 0.03% | 81 |
|
|
2022
Q4 | $14.1M | Buy |
2,399,252
+292,284
| +14% | +$1.72M | 0.05% | 86 |
|
|
2022
Q3 | $6.74M | Hold |
2,106,968
| – | – | 0.02% | 100 |
|
|
2022
Q2 | $9.44M | Buy |
2,106,968
+200,000
| +10% | +$896K | 0.03% | 95 |
|
|
2022
Q1 | $10.2M | Buy |
1,906,968
+480,000
| +34% | +$2.56M | 0.02% | 102 |
|
|
2021
Q4 | $21M | Buy |
1,426,968
+429,979
| +43% | +$6.32M | 0.04% | 105 |
|
|
2021
Q3 | $20.8M | Hold |
996,989
| – | – | 0.04% | 112 |
|
|
2021
Q2 | $17.6M | Sell |
996,989
-1,072
| -0.1% | -$19K | 0.03% | 117 |
|
|
2021
Q1 | $24.5M | Buy |
998,061
+100,000
| +11% | +$2.45M | 0.04% | 102 |
|
|
2020
Q4 | $30.4M | Buy |
898,061
+595,000
| +196% | +$20.1M | 0.05% | 99 |
|
|
2020
Q3 | $7.58M | Buy |
+303,061
| New | +$7.58M | 0.01% | 111 |
|